Butterfly Network signs multi-year ultrasound-on-chip licensing deal with Merge Labs for BCI development

• Butterfly Network signed a multi-year licensing deal with Merge Labs to support ultrasound-based brain-computer interface development.
• Merge gains access to Butterfly’s Poseidon Ultrasound-on-Chip technology through Butterfly Embedded.
• Terms include upfront payments, milestone-based license fees, hardware purchase commitments, technology access fees, ongoing royalties on future commercial sales.
• Butterfly becomes Merge’s exclusive CMOS-MEMS chip-based ultrasound partner, while retaining rights to license its technology to others.
• Merge launched in January 2026 with USD 252 million in seed funding from investors including OpenAI, Bain Capital, Interface Fund.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Butterfly Network Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609010805BIZWIRE_USPR_____20260901_BW999280) on September 01, 2026, and is solely responsible for the information contained therein.